首页> 美国卫生研究院文献>other >Oxidative Stress-responsive Transcription Factor NRF2 is Not Indispensable For The Human Hepatic Flavin-Containing Monooxygenase-3 (FMO3) Gene Expression in HepG2 Cells
【2h】

Oxidative Stress-responsive Transcription Factor NRF2 is Not Indispensable For The Human Hepatic Flavin-Containing Monooxygenase-3 (FMO3) Gene Expression in HepG2 Cells

机译:氧化应激响应转录因子NRF2并非人类肝黄素单加氧酶3(FMO3)基因在HepG2细胞中的表达。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The flavin-containing monooxygenases (FMOs) are important for the oxidation of a variety of endogenous compounds and xenobiotics. The hepatic expression of FMO3 is highly variable and until recently, it was thought to be uninducible. In this study, human FMO3 gene regulation by the oxidative stress transcription factor, nuclear factor (erythroid-derived 2)-like 2 (NRF2) was examined. Constitutive FMO3 gene expression is repressed in HepG2 cells, thus this cell can be a good model for FMO3 gene regulation studies. Over-expression of NRF2 in HepG2 cells increased NRF2 target gene expression, heme oxygenase-1 (HMOX1) and NAD(P)H:quinone oxidoreductase-1 (NQO1), but did not alter FMO3 gene expression. Co-transfection studies with NRF2 or its cytosolic regulatory protein, Kelch-like ECH-associated protein 1 (KEAP1), expression vectors, along with FMO3 promoter luciferase reporter constructs of various lengths (5Kb or 6Kb), did not change FMO3 reporter gene activity significantly. Furthermore, treatment with tert-butyl hydroperoxide (tBHP) and tert-butyl hydroquinone (tBHQ) did not alter FMO3 reporter construct activity. In summary, in vitro results suggest that the transcriptional regulation of FMO3 might not involve the NRF2-KEAP1 regulatory pathway.
机译:含黄素的单加氧酶(FMO)对于多种内源性化合物和异种生物的氧化非常重要。 FMO3的肝表达高度可变,直到最近,仍被认为是不可诱导的。在这项研究中,研究了人类FMO3基因受氧化应激转录因子,核因子(类胡萝卜素2)样2(NRF2)的调控。组成性FMO3基因表达在HepG2细胞中受到抑制,因此该细胞可以成为FMO3基因调控研究的良好模型。 NRF2在HepG2细胞中的过表达增加了NRF2靶基因表达,血红素加氧酶-1(HMOX1)和NAD(P)H:醌氧化还原酶-1(NQO1),但没有改变FMO3基因表达。与NRF2或其胞质调节蛋白,Kelch样ECH相关蛋白1(KEAP1),表达载体以及各种长度(5Kb或6Kb)FMO3启动子荧光素酶报告基因构建体的共转染研究均未改变FMO3报告基因的活性显着。此外,用叔丁基氢过氧化物(tBHP)和叔丁基氢醌(tBHQ)处理不会改变FMO3报告基因构建体的活性。总之,体外结果表明FMO3的转录调控可能不涉及NRF2-KEAP1调控途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号